Giuseppe D’Ancona*, MD, PhD; Stephan Kische, MD, PhD; Hüseyin U. Agma, MD; Hüseyin Ince, MD, PhD
Department of Cardiology, Vivantes Klinikum im Friedrichshain und Am Urban, Berlin, Germany and Rostock University Medical Center, Rostock, Germany
Secondary mitral regurgitation (MR) has acomplex pathophysiology that includes global or segmental left ventricular (LV) motion abnormalities (of non-ischaemic or ischaemic origin) leading to impaire